Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Nehal J. Lakhani

2-Methoxyestradiol, a promising anticancer agent

scientific journal article

A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer

scientific article

A retrospective analysis of tolerance and outcomes of cutaneous malignant melanoma in patients receiving adjuvant interferon-alpha 2B: a community oncology perspective

scientific article published on September 2017

ANG1005, a brain penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases

scientific article published on 22 January 2020

Antiangiogenesis therapeutic strategies in prostate cancer

scientific article

Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol

scientific article published on 01 July 2007

Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry

scientific article

Determination of the antiangiogenesis agent 2-methoxyestradiol in human plasma by liquid chromatography with ultraviolet detection

scientific article

Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board

scientific article published on 30 August 2015

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

scientific article published on 01 August 2020

Efficacy proof-of-concept from a phase 1 study of a novel therapeutic peptide, ST101, targeting the oncogenic transcription factor C/EBPβ in patients with refractory solid tumors.

scientific article published in 2022

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

scientific article published on 27 February 2019

Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer

scientific article published in March 2003

Pharmacogenetics of estrogen metabolism and transport in relation to cancer

scientific article published on December 2003

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

scientific article published on 22 January 2006

Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors

scientific article published on 28 September 2020

Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas

scientific article

Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol

scientific article published on 01 September 2006

Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

scientific article published on 01 October 2020

Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review

scientific article